Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

JAN 30, 2013 - Benzinga

A Must Read - Share

UPDATE: Goldman Sachs Raises PT to $32 on Pfizer on Breakup Optionality

Goldman Sachs maintained Pfizer, Inc. (NYSE: PFE) with a Buy rating and raises the price target from $30.00 to $32.00. Goldman Sachs commented, "PFE reported 4Q12 earnings and gave 2013 financial guidance which included highlighting efforts to optimize both the innovation-driven and value-based businesses as distinct entities.

Tags: UPDATE: Goldman Sachs Raises PT to $32 on Pfizer on Breakup Optionality,  Pfizer Latest News